Back to Capital Research Global Investors Capital Research Global Investors

ABTABT
Showing 8 of 31 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in ABBOTT LABORATORIES

Capital Research Global Investors holds 36.9M shares of ABT (ABBOTT LABORATORIES), worth $3.3B as of 2026-Q2. The position was decreased (-25.9% shares). ABT represents 0.5% of Capital Research Global Investors's portfolio.

Current Value

$3.3B

Current Shares

36.9M

Total Value Change

-$2.7B

Total Shares Change

-16.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
36.9M
-25.9%
$3.3B0.5%$90.10
0
2026-Q1
Increased
49.8M
+27.1%
$5.1B0.8%$101.31
56
2025-Q4
Increased
39.2M
+1.0%
$4.9B0.9%$123.00
45
2025-Q3
Decreased
38.8M
-7.2%
$5.2B1.0%$130.91
0
2025-Q2
Decreased
41.8M
-17.7%
$5.7B1.1%$132.34
0
2025-Q1
Decreased
50.7M
-6.2%
$6.7B1.5%$128.48
0
2024-Q4
Increased
54.1M
+1.5%
$6.1B1.3%$108.98
51
2024-Q3
Decreased
53.3M
-6.9%
$6.1B1.3%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used